Pancreatin Triple Strength Cap



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 29.2%
Cystic Fibrosis 12.5%
Pancreatic Carcinoma 8.3%
Blood Pressure 4.2%
Gastrooesophageal Reflux Disease 4.2%
Ill-defined Disorder 4.2%
Inhalation Therapy 4.2%
Pancreatic Disorder 4.2%
Pancreatic Insufficiency 4.2%
Weight Decreased 4.2%
Acne 2.1%
Anxiety 2.1%
Contraception 2.1%
Dyspnoea 2.1%
Gastric Disorder 2.1%
Gastric Ulcer 2.1%
Gastrointestinal Disorder 2.1%
Hypertension 2.1%
Malnutrition 2.1%
Mineral Supplementation 2.1%
Drug Ineffective 10.5%
Abdominal Pain Upper 5.3%
Abnormal Faeces 5.3%
Breast Pain 5.3%
Dysgeusia 5.3%
Expired Drug Administered 5.3%
Flatulence 5.3%
Frequent Bowel Movements 5.3%
Glycosylated Haemoglobin Increased 5.3%
Nausea 5.3%
Refusal Of Treatment By Patient 5.3%
Steatorrhoea 5.3%
Urticaria 5.3%
Vomiting 5.3%
Vulvovaginal Discomfort 5.3%
Weight Decreased 5.3%
Weight Gain Poor 5.3%
Wheezing 5.3%
Secondary
Product Used For Unknown Indication 27.9%
Pancreatic Carcinoma 18.6%
Bile Duct Cancer 14.0%
Vomiting 7.0%
Dyspepsia 4.7%
Supplementation Therapy 4.7%
Cerebrovascular Accident 2.3%
Gastric Disorder 2.3%
Gastric Ulcer 2.3%
Hypertension 2.3%
Ill-defined Disorder 2.3%
Nausea 2.3%
Pancreatectomy 2.3%
Pancreatic Disorder 2.3%
Pancreaticoduodenectomy 2.3%
Peripheral Nerve Destruction 2.3%
Vomiting 27.3%
Drug Ineffective 18.2%
Glycosylated Haemoglobin Increased 9.1%
Lipase Increased 9.1%
Refusal Of Treatment By Patient 9.1%
Suicide Attempt 9.1%
Urticaria 9.1%
Weight Decreased 9.1%
Concomitant
Drug Use For Unknown Indication 24.8%
Medical Diet 8.0%
Diabetes Mellitus 7.3%
Product Used For Unknown Indication 5.8%
Neoplasm 5.6%
Prophylaxis 5.2%
Coronary Artery Disease 4.3%
Crohn's Disease 4.3%
Pain 4.3%
Pancreatic Carcinoma Metastatic 4.1%
Flatulence 3.7%
Hypertension 3.5%
Pancreatic Carcinoma 3.0%
Constipation 2.8%
Dyspepsia 2.4%
Rheumatoid Arthritis 2.4%
Back Pain 2.2%
Chronic Obstructive Pulmonary Disease 2.2%
Cystic Fibrosis 2.2%
Stomatitis 1.9%
Transplant Rejection 11.1%
Death 9.5%
Pyrexia 7.9%
Vomiting 7.9%
Deafness Unilateral 6.3%
Circulatory Collapse 4.8%
Mucosal Inflammation 4.8%
Pain In Extremity 4.8%
Renal Failure 4.8%
Sepsis 4.8%
Weight Decreased 4.8%
Abdominal Distension 3.2%
Atrial Fibrillation 3.2%
Diarrhoea 3.2%
Lung Neoplasm 3.2%
Pericardial Effusion 3.2%
Platelet Count Increased 3.2%
Respiratory Tract Infection 3.2%
Staphylococcal Infection 3.2%
Tumour Haemorrhage 3.2%